期刊文献+

野生型DNA聚合酶β转染Eca-109细胞后增变基因表型变化 被引量:1

Changes of mutator phenotypes in Eca-109 cells transfected with wild type DNA polymerase beta
下载PDF
导出
摘要 目的:探讨野生型DNA聚合酶β(polbeta)转染人食管癌Eca-109细胞后对其增变基因表型的效应。方法:将经过鉴定的重组pcDNA3.1质粒(插入野生型,wt)-polbeta转染培养的人食管癌Eca-109细胞。将Eca-109细胞分为3组:转染实验组(E)、空质粒转染对照组(C1)和未转染对照组(C2)。应用原位杂交技术显示wt-polbeta和wt-p53的杂交信号,免疫细胞化学染色显示POLB-免疫反应性(IR)和多药耐受(MDR1)-IR,免疫印迹显示wt-polbeta和突变(mt)-polbeta的带型,细胞化学技术检测各组细胞的增殖与分化细胞的比率。结果:polbeta免疫印迹结果显示E组呈现增强的wt-polbeta主带,C1、C2组呈现很弱wt-polbeta主带和显著突变的(mt)-polbeta主带(P<0.01);polbeta免疫细胞化学结果显示E组的强信号定位于细胞核内,C1、C2组信号皆很弱(P<0.01)。E组的wt-polbeta及wt-p53原位杂交的信号强于C1、C2组(P<0.01)。E组MDR1的免疫反应性和增殖与分化细胞的比率低于C1、C2组(P<0.01)。结论:wt-polbeta转染的Eca-109细胞呈现wt-polbeta及wt-p53表达上调而mt-polbeta及MDR1表达下调的增变基因表型减弱。 Aim: To explore the effects on polbeta-overexpressed human esophageal cancer Eca-109 cells transfected with wild type(wt)-polbeta.Methods:The identified recombinant pcDNA 3.1 was transfected into the Eca-109 cells,and the cultured cells were divided into 3 groups: transfected experimental group(E),empty plasmid control group(C1),and untransfected control group(C2).The expressions of polbeta,p53,MDR1,and the ratio of proliferating/differentiated cells were detected by in situ hybridization,immunocytochemistry,immunoblotting,and cytochemisrtry techniques,respectively.Results: The immuoblotting showed that there was an enhanced band of wt-polbeta in E group,while a distinct major band of mt-polbeta in C1/C2 group(P〈0.01).In polbeta immunocytochemistry the signals located in the nuclei were much stronger in E group than those in C1/C2 group(P〈0.01).In situ hybridization the signals of wt-polbeta and wt-p53 located in the cytoplasm were markedly stronger in E group than those in C1/C2 group(P〈0.01);whereas,the MDR1-immunoreactivity(IR) and the ratio of proliferating cells versus differentiated cells were much decreased in E group than those in C1/C2 group(P〈0.01).Conclusion: In the transfected Eca-109 cells the expressions of wt-polbeta and wt-p53 are up-regulated and those of the mt-polbeta and MDR1 are down-regulated,which exhibites reduction of the mutator phenotype.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2008年第6期1085-1090,共6页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目39870287 河南省科技攻关基金资助项目
关键词 野生型DNA聚合酶β 转染 DNA聚合酶β-p53-MDR1表达亚群 增变基因表型 ECA-109细胞 wild type DNA polymerase beta transfection DNA polymerase beta-p53-MDR1 subset expression mutator phenotype Eca-109 cell
  • 相关文献

参考文献3

二级参考文献31

  • 1戚晓东,杨之斌,韩德民,倪鑫,牛旗,李志新,姜乃佳.“今又生”治疗晚期恶性肿瘤的疗效观察(附23例)[J].现代肿瘤医学,2006,14(10):1295-1297. 被引量:19
  • 2药理学.江明性主编[M].北京:人民卫生出版社,2000..
  • 3Cho-Chung YS. Role of cyclic AMP receptor protein in growth, differentiation and suppression of malignancy: New approaches to therapy. Cancer Res, 1990, 50(22) :7 093.
  • 4Singhal RK, Wilson LH. Short gap-filling synthesis by DNA polymerase beta is processive. J Biol Chem,1993, 268(21) :15906.
  • 5Hill BT, Scanlon KJ, Hansson J, et al. Deficient repair of cisplatin-DNA adducts identified in human testlcular teratoma cell lines established from tumors from untreated patients. Eur J Cancer,1994, 30A(6) :832.
  • 6Valentines B, Zaffaroni N, Sturani E, et al. Detection of DNA polymerase beta gene expression by competive polymerase chain reaction in human ovarian carcinoma cells. Anticancer Res,1993, 13(1) :125.
  • 7Funato T, Tone T, Miyachi H, et al. Detection of drug resistant-gene in cisplatin-resistant colon carcinoma cells by RT-PCR assay. Rinsho Byori,1993, 41 (1) :95.
  • 8Canitrot Y, Cazaux C, Frechet M, et al. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.Proc Natl Acad Sci USA,1998,95(21):12586.
  • 9Hollstein M,Sidransky D,Vogelstein B,et al.p53 mutations in human cancers[J].Science,1991,253(5015):49-53.
  • 10Karja VJ,Syrjanen KJ,Kurvinen AK,et al.Expression and mutations of p53 in salivary gland tumours[J].J Oral Pathol Med,1997,26(5):217-223.

共引文献13

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部